FindTrial
Sign In

Establishment of PK/PD Model for Aripiprazole in the Elderly Population and Exploration of Individualized Medication

Establishment of PK/PD Model for Aripiprazole in the Elderly Population and Exploration of Individualized Medication

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500112699
Enrollment
Unknown
Registered
2025-11-18
Start date
2026-01-01
Completion date
Unknown
Last updated
2025-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Schizophrenia

Interventions

Observation group:None

Sponsors

Hangzhou First People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
65 Years to 100 Years

Inclusion criteria

Inclusion criteria: 1. Elderly individuals aged 65 years or older; 2. Diagnosed with schizophrenia; 3. Currently receiving or initiating treatment with aripiprazole tablets.

Exclusion criteria

Exclusion criteria: 1. Type I or Type II diabetes mellitus; 2. Previous use of other antipsychotic medications within the past 6 months; 3. Known diagnosis of long QT syndrome.

Design outcomes

Primary

MeasureTime frame
Abnormal Involuntary Movement Scale, AIMS;Epworth Sleepiness Scale, ESS;Body weight;Aberrant Behavior Checklist, ABC;Clinical Global Impression, CGI;—

Secondary

MeasureTime frame
BUN;Cr;;;—

Countries

China

Contacts

Public ContactXu Danhua

Hangzhou First People's Hospital

471689939@qq.com+86 153 5671 1030

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026